Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol for blood loss reduction during myomectomy
ACTRN12621000808842Phase 4Recruiting
- Sponsor
- Royal Women's Hospital Human Research and Ethics Committee
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Fibromyoma (LM) comparing Misoprostol with Placebo (2 arms). Primary endpoint: Intraoperative blood loss. Started Sep 2018; status: recruiting.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ACTRN12621000808842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000808842.